SAB Biotherapeutics, Inc 10-K for FY2021
SAB Biotherapeutics, Inc. (SABS)
10-K
2022-03-29
For: 2021-12-31
View Original
Added on
April 10, 2026
About this 10-K
SAB Biotherapeutics, Inc filed this 10-K on March 29, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $60.88M
- up 10.2% from $55.24M a year earlier
- Net loss
- $17.14M
- compared with net income of $20.12M a year earlier
- Diluted EPS
- -$0.63
- compared with $0.74 a year earlier